Cargando…
The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes
Autores principales: | Eng, Pei Chia, Distaso, Walter, Durreshahwar, Hashmi, Shaikhali, Yusuf, Narendranathan, Divani, Cassin‐Scott, Rebecca, Misra, Shivani, Hill, Neil E., Tharakan, George, Oliver, Nick S., Tan, Tricia M., Izzi‐Engbeaya, Chioma, Salem, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111414/ https://www.ncbi.nlm.nih.gov/pubmed/35293117 http://dx.doi.org/10.1111/dom.14692 |
Ejemplares similares
-
Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
por: Eng, Pei Chia, et al.
Publicado: (2023) -
The acute effect of glucagon on components of energy balance and glucose homoeostasis in adults without diabetes: a systematic review and meta-analysis
por: Frampton, James, et al.
Publicado: (2022) -
Using Aptamers as a Novel Method for Determining GnRH/LH Pulsatility
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2020) -
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2021) -
THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)